Further analysis revealed that those mutant MED1 LxxLL mutant tumor cells had a lower expression of both traditional ER-target genes including IGF-1 and cyclin D1, and HER2 activated ER-target genes such as LIF and ACP6 [57]. This evidence concerns the gene ESR1 and neoplasm.